MA26980A1 - Antagonistes des recepteurs d'histamine. - Google Patents

Antagonistes des recepteurs d'histamine.

Info

Publication number
MA26980A1
MA26980A1 MA27233A MA27233A MA26980A1 MA 26980 A1 MA26980 A1 MA 26980A1 MA 27233 A MA27233 A MA 27233A MA 27233 A MA27233 A MA 27233A MA 26980 A1 MA26980 A1 MA 26980A1
Authority
MA
Morocco
Prior art keywords
receptor antagonists
histamine receptor
histamine
receptor
antagonist
Prior art date
Application number
MA27233A
Other languages
English (en)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA26980A1 publication Critical patent/MA26980A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Antagonistes des récepteurs d'histamine La présente invention propose une association (a) d'un antagoniste des récepteurs d'histamine H1 et (b) d'un antagoniste qui est au moins 10 fois plus sélectif pour le récepteur d'histamine H4 que pour le récepteur d'histamine H3, des compositions la contenant ainsi que leurs utilisations.
MA27233A 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine. MA26980A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
MA26980A1 true MA26980A1 (fr) 2004-12-20

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27233A MA26980A1 (fr) 2001-01-17 2003-07-11 Antagonistes des recepteurs d'histamine.

Country Status (31)

Country Link
EP (1) EP1353657A1 (fr)
JP (1) JP2004517883A (fr)
KR (1) KR20030069216A (fr)
CN (1) CN1486178A (fr)
AP (1) AP2002002401A0 (fr)
AR (1) AR032101A1 (fr)
BG (1) BG107834A (fr)
BR (1) BR0206502A (fr)
CA (1) CA2435121A1 (fr)
CR (1) CR6983A (fr)
CZ (1) CZ20031853A3 (fr)
DO (1) DOP2002000325A (fr)
EA (1) EA200300537A1 (fr)
EC (1) ECSP034692A (fr)
EE (1) EE200300335A (fr)
GB (1) GB0101223D0 (fr)
GT (1) GT200200003A (fr)
HU (1) HUP0302767A2 (fr)
IL (1) IL156087A0 (fr)
IS (1) IS6818A (fr)
MA (1) MA26980A1 (fr)
MX (1) MXPA03006408A (fr)
NO (1) NO20033223L (fr)
OA (1) OA12440A (fr)
PA (1) PA8537101A1 (fr)
PL (1) PL362793A1 (fr)
SK (1) SK8572003A3 (fr)
SV (1) SV2003000849A (fr)
TN (1) TNSN02003A1 (fr)
WO (1) WO2002056871A2 (fr)
ZA (1) ZA200304180B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
JP2006510590A (ja) * 2002-09-06 2006-03-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ アレルギー及び喘息の処置のためのヒスタミンh4受容体モジュレーターの使用
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (fr) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Méthodes et composés utiles pour traiter le prurit, et procédés d'identification desdits composés
ES2683380T3 (es) 2012-06-08 2018-09-26 Sensorion Inhibidores del receptor H4 para tratar el tinnitus

Also Published As

Publication number Publication date
AP2002002401A0 (en) 2002-03-31
CN1486178A (zh) 2004-03-31
EE200300335A (et) 2003-12-15
OA12440A (en) 2006-05-22
DOP2002000325A (es) 2003-01-31
NO20033223D0 (no) 2003-07-16
CR6983A (es) 2003-11-25
SK8572003A3 (en) 2004-07-07
EP1353657A1 (fr) 2003-10-22
CA2435121A1 (fr) 2002-07-25
IS6818A (is) 2003-05-15
JP2004517883A (ja) 2004-06-17
ECSP034692A (es) 2003-08-29
PL362793A1 (en) 2004-11-02
GT200200003A (es) 2002-08-19
SV2003000849A (es) 2003-01-13
KR20030069216A (ko) 2003-08-25
BR0206502A (pt) 2003-10-21
WO2002056871A2 (fr) 2002-07-25
HUP0302767A2 (hu) 2003-11-28
GB0101223D0 (en) 2001-02-28
EA200300537A1 (ru) 2004-02-26
TNSN02003A1 (fr) 2005-12-23
CZ20031853A3 (cs) 2004-07-14
ZA200304180B (en) 2004-06-15
AR032101A1 (es) 2003-10-22
NO20033223L (no) 2003-07-16
PA8537101A1 (es) 2002-08-29
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
MXPA03006408A (es) 2003-10-15

Similar Documents

Publication Publication Date Title
Tabakowska et al. Językoznawstwo kognitywne a poetyka przekładu
ES2145425T3 (es) Comprimidos de valaciclovir que contienen dioxido de silicio coloidal.
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
WO1999048523A3 (fr) Antagonistes de mediateurs inflammatoires
TNSN06187A1 (fr) Arylpyrazoles substitues servant d'agents parasiticides
WO2003048207A3 (fr) Anticorps dirige contre le dota
MXPA03010158A (es) Sulfonamidas.
MA27921A1 (fr) Systemes emulsifiants contenant des derives d'azetidine
MY135957A (en) Hard precious metal alloy member and method of manufacturing the same
MA26980A1 (fr) Antagonistes des recepteurs d'histamine.
DE60138228D1 (de) Metallothermische reduktion von oxiden feuerfester metalle
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
FR2863825B1 (fr) Solutions de cipc et d'un terpene ou d'une huile terpenique et leurs utilisations pour le traitement antigerminatif de bulbes ou tubercules
SE0302370D0 (sv) Delay compositions and detonation delay devices utilizing same
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
IL160272A0 (en) Pharmaceutical compositions containing a pde4 or a pde3/4 inhibitor and a leukotriene receptor antagonist
WO2002089740A3 (fr) Sulfonamides
GT199900037A (es) Nuevas composiciones herbicidas.
MA27114A1 (fr) Nouvelle association d'un antithrombotique et d'aspirine
FR2791661B1 (fr) Nouvelles compositions d'oxydes metalliques, des capteurs semi-conducteurs prepares a partir d'une telle composition et leurs utilisations pour la detection des gaz.
FR2860436B1 (fr) Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire
ATE401257T1 (de) Einzeldosisverpackung
ATE346023T1 (de) Monolithisch aufgebauter, basischer, feuerfester keramischer hohlkörper
ATE273792T1 (de) Verbundelemente enthaltend bitumen
DE50212676D1 (de) Exopolysaccharidproduktion